re: Ann: Gindalbie Completes Final Stage of E... Here is one of the reason. Another $200m debt is on the way to cover loss on loan due to AUD appreciation.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%